Nope. Not the only way Art.
This concept of the family unilaterally trashing their notes leads to a dead-end street. Not happening UNILATERALLY imo. Ironically, I’m encouraged that this concept has resurfaced lately given the NoPain Act/CMS insurance reimbursement being front and center here, and especially seeing it might commence in 2024 instead of 2025, as the push is on by influencers.
I ran a prior take on how these notes could be handled, and not unilaterally. Just one example, and it’s not the only one to be had, but the only one offered to illustrate one thing…
…think outside the box when it comes to negotiations…
Anyone thinking they are going to merge or partner with the company by demanding the family surrender convertible notes without any comparable reimbursement by not “thinking outside the box”, is dead in the water for a second seating at the negotiation table imo.
Should a M&A see the value of the “Act” with CMS insurance reimbursement as significantly bloating their already pronounced bottom line earnings, they will come to an acceptable agreement, more likely with a plug n play company.
BIEL is not in a position of monetary strength from my view, but they are in a position of newfound enhanced strength GOING FORWARD given the ACT & CMS insurance reimbursements.
It will be pocket change for the prospect, yet still an amazing deal for BIEL and all should it happen.
Money is relative to one’s resources. Turnkey, 5 FDA approvals, patents, is relative to money.
Combined the two. Hmm.
All imo.
